We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$494M
AUM Growth
+$42.4M
Cap. Flow
+$2.18M
Cap. Flow %
0.44%
Top 10 Hldgs %
32.01%
Holding
118
New
13
Increased
22
Reduced
42
Closed
11

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$13.6M
2
JPM icon
JPMorgan Chase
JPM
+$11.4M
3
PNC icon
PNC Financial Services
PNC
+$10.8M
4
MMM icon
3M
MMM
+$9.29M
5
SIVB
SVB Financial Group
SIVB
+$8.99M

Sector Composition

Rank Sector Weight
1 Technology 27.08%
2 Healthcare 20.57%
3 Financials 20.37%
4 Industrials 10.13%
5 Consumer Discretionary 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBUX icon
51
Starbucks
SBUX
$117B
$2.8M 0.57%
48,700
-100
-0.2% -$5.66K
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$120B
$2.68M 0.54%
17,900
-17,700
-50% -$2.62M
ILMN icon
53
Illumina
ILMN
$29.7B
$2.46M 0.5%
11,565
-4,523
-28% -$931K
WTRG icon
54
Essential Utilities
WTRG
$11.2B
$2.44M 0.49%
+62,100
New +$2.26M
ALXN
55
DELISTED
Alexion Pharmaceuticals
ALXN
$2.4M 0.49%
20,096
-354
-2% -$43.1K
GILD icon
56
Gilead Sciences
GILD
$162B
$2.2M 0.45%
30,675
-800
-3% -$60.8K
ATO icon
57
Atmos Energy
ATO
$29.8B
$2.18M 0.44%
25,400
EW icon
58
Edwards Lifesciences
EW
$48.1B
$2.13M 0.43%
56,700
CHD icon
59
Church & Dwight Co
CHD
$22.6B
$2.08M 0.42%
41,400
-35,000
-46% -$1.64M
CCI icon
60
Crown Castle
CCI
$32.5B
$2.02M 0.41%
18,250
+100
+0.6% +$10.8K
MASI
61
DELISTED
Masimo
MASI
$1.96M 0.4%
23,100
VZ icon
62
Verizon
VZ
$183B
$1.76M 0.36%
33,349
-369
-1% -$18.1K
VLO icon
63
Valero Energy
VLO
$90.9B
$1.75M 0.35%
+19,000
New +$1.57M
FBIN icon
64
Fortune Brands Innovations
FBIN
$5.91B
$1.73M 0.35%
29,543
-34,164
-54% -$1.94M
ESRX
65
DELISTED
Express Scripts Holding Company
ESRX
$1.51M 0.31%
20,255
-645
-3% -$41.3K
GIS icon
66
General Mills
GIS
$19.1B
$1.46M 0.3%
24,600
T icon
67
AT&T
T
$158B
$1.4M 0.28%
47,810
-1,306
-3% -$35.7K
NBIX icon
68
Neurocrine Biosciences
NBIX
$17.6B
$1.31M 0.27%
16,900
-800
-5% -$54.6K
CTSH icon
69
Cognizant
CTSH
$20.2B
$1.12M 0.23%
15,800
-100,900
-86% -$7.37M
NKE icon
70
Nike
NKE
$60.6B
$1.11M 0.23%
17,800
META icon
71
Meta Platforms (Facebook)
META
$1.53T
$1.11M 0.23%
6,300
-46,500
-88% -$8.22M
CMD
72
DELISTED
Cantel Medical Corporation
CMD
$1.09M 0.22%
10,600
BCE icon
73
BCE
BCE
$19.8B
$1.06M 0.21%
22,111
ADI icon
74
Analog Devices
ADI
$183B
$1.03M 0.21%
11,600
PG icon
75
Procter & Gamble
PG
$340B
$1.01M 0.2%
11,002

Similar funds

De Burlo Group's Q4 2017 Portfolio in Review

As of Q4 2017, De Burlo Group held 118 positions worth $494M, up 9.4% from $451M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

De Burlo Group's Q4 2017 filing shows 13 new, 22 increased, 42 reduced and 11 closed positions. Its largest new stake was JPMorgan Chase: 113,000 shares worth $12.1M. The largest sale was American Tower, an estimated $12M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • De Burlo Group's largest Q4 2017 buy was JPMorgan Chase: 113,000 shares worth $12.1M.
  • De Burlo Group added most to Mastercard in Q4 2017, an estimated $13.6M increase.
  • De Burlo Group's biggest Q4 2017 reduction was American Tower, cutting an estimated $12M.
  • De Burlo Group fully exited Azenta in Q4 2017, selling an estimated $5.23M.
  • De Burlo Group's ten largest holdings make up 32% of its $494M portfolio in Q4 2017.
  • De Burlo Group opened 13 new positions and closed 11 in Q4 2017.
  • De Burlo Group's portfolio value rose 9.4% quarter-over-quarter to $494M.

Based on De Burlo Group's 13F filing for Q4 2017, filed 8 Feb 2018.